Why the study?
The appropriate anticoagulation regimen following transcatheter mitral valve replacement remains a matter of debate.
Population
One 78-year-old frail female with heart failure, AF, and prior mitral valve annuloplasty undergoing TMVR
Design
Case report
Authors
Loading...
Alerts clinicians to post-TMVR anticoagulation risks in frail AF patients; leaves open optimal regimens for prospective trials.
Withdrawal of oral anticoagulation after TMVR in patients with atrial fibrillation and prior LAA excision can lead to massive LA thrombus, suggesting anticoagulation should be maintained despite LAA closure.
Maloku et al. (2024) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: